Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se

Peritoneal Dialysis International

Volumn 23, Issue 4, 2003, Pages 381-390

  Witowski, Janusz ^a,b   Bender, Thorsten O ^a   Wisniewska Elnur, Justyna ^b   Ksiazek, Krzystof ^b   Passlick Deetjen, Jutta ^c   Breborowicz, Andrzej ^b   Jörres, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Biocompatibility; Dialysis fluids; Glucose degradation products; Mesothelial cells

Indexed keywords

GLUCOSE; GLUCOSE DEGRADATION PRODUCT; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID;

ARTICLE; AUTOCLAVE; BIOCOMPATIBILITY; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; FILTRATION; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; INCUBATION TIME; INSTRUMENT STERILIZATION; MESOTHELIUM CELL; PH; PRIORITY JOURNAL;

CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; EPITHELIUM; GLUCOSE; HUMANS; INTERLEUKIN-6; PERITONEAL DIALYSIS; PERITONEUM;

EID: 0042420732     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
2. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
3. Nilsson Thorell CB, Muscalu N, Andren AH, Kjellstrand PT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
4. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
5. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11:729-39.
6. Witowski J, Jörres A. Glucose degradation products: relationship with cell damage. Perit Dial Int 2000; 20(Suppl 2):S31-6.
7. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-70.
8. Tauer A, Knerr T, Niwa T, Schaub TP, Lage C, Passlick-Deetjen J, et al. In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem Biophys Res Commun 2001; 280: 1408-14.
9. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995; 47:282-93.
10. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
11. Topley N. What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions? Perit Dial Int 1995; 15:205-9.
12. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41:1280-5.
13. Witowski J, Knapowski J. Glycerol toxicity for human peritoneal mesothelial cells in culture: comparison with glucose. Int J Artif Organs 1994; 17:252-60.
14. Wieslander AP, Kjellstrand PT, Rippe B. Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations. Perit Dial Int 1995; 15(7 Suppl):S52-9.
15. Breborowicz A, Polubinska A, Oreopoulos DG. Changes in volume of peritoneal mesothelial cells exposed to osmotic stress. Perit Dial Int 1999; 19:119-23.
16. Matsuoka Y, Yamauchi A, Nakanishi T, Sugiura T, Kitamura H, Horio M, et al. Response to hypertonicity in mesothelial cells: role of Na+/myo-inositol co-transporter. Nephrol Dial Transplant 1999; 14:1217-23.
17. Horio M, Yamauchi A, Matsuoka Y, Moriyama T, Fukunaga M, Imai E, et al. Effect of hypertonic stress on amino acid levels and system A activity in rat peritoneal mesothelial cells. Perit Dial Int 1999; 19:124-30.
18. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15:158-64.
19. Arbeiter K, Bidmon B, Endemann M, Bender TO, Eickelberg O, Ruffingshofer D, et al. Peritoneal dialysate fluid composition determines heat shock protein expression patterns in human mesothelial cells. Kidney Int 2001; 60:1930-7.
20. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
21. Visser CE, Brouwer Steenbergen JJ, Betjes MG, Koomen GC, Beelen RH, Krediet RT. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10:64-9.
22. Järklid LE, Deppisch R, Wieslander A. Presence of GDP in PD fluids decreases ex vivo mesothelial cell regeneration [Abstract]. Perit Dial Int 1999; 19(Suppl 1):S54.
23. Tuncer M, Sarikaya M, Sezer T, Ozcan S, Suleymanlar G, Yakupoglu G, et al. Chemical peritonitis associated with high dialysate acetaldehyde concentrations. Nephrol Dial Transplant 2000; 15:2037-40.
24. Cronauer MV, Stadlmann S, Klocker H, Abendstein B, Eder IE, Rogatsch H, et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol 1999; 155: 1977-84.
25. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-88.
26. Martin J, Yung S, Robson RL, Steadman R, Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000; 20:524-33.
27. Lamb EJ, Cattell WR, Dawnay AB. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47:1768-74.
28. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14: 1541-9.
29. Ogata S, Yorioka N, Nishida Y, Shao JC, Yamakido M. Expression of receptor for advanced glycation end product mRNA by human peritoneal mesothelial cells. Nephron 2000; 86:245-6.
30. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002; 61:148-56.